Skip to main content
Fig. 4 | International Journal of Retina and Vitreous

Fig. 4

From: Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties

Fig. 4

SEC of faricimab. (a) Representative chromatograms for vial, D0-n, D7-n and -c, D14-c, and D37-c are displayed as start and endpoint storage conditions. (b) We calculated the area under curve for all 9 syringes for vial, D0-n, D7-n and -c, D14-c, and D37-c. ns = non-significant, D = day, n = needle, c = cap

Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us